Luxempart

Equities

LXMPR

LU2605908552

Investment Management & Fund Operators

End-of-day quote LUXEMBOURG S.E. Other stock markets 06/03/2026			5-day change	1st Jan Change
61.50 ^EUR	-2.38%		-0.81%	-2.38%

02-09	Luxempart S.A. Initiates Succession Process for Managing Director, John Penning	CI
12-19	Luxempart to Become Majority Shareholder in Valeara	MT

Luxempart agreed to acquire an unknown majority stake in VALEARA Bottrop GmbH from GENUI GmbH and others.

Published on 12/18/2025

S&P Capital IQ

LUXEMPART

-2.38%

COMMERZBANK AG

-2.14%

ALANTRA PARTNERS, S.A.

-0.45%

Luxempart (BDL:LXMPR) agreed to acquire an unknown majority stake in VALEARA Bottrop GmbH from GENUI GmbH and others on December 19, 2025. GENUI remains invested as a shareholder.

The transaction is expected to close in the first quarter of 2026.

Andreas Hoffmann, Martin Brinkfort, Holger Redle, Philipp Jans, Philipp Kruse of BPG Beratungs- und Prüfungsgesellschaft mbH act as accountant for GENUI GmbH. Christopher Wolff, Melchior Raiser, Jan Gernoth, Julian Schmitz, Mahmood Kawany, Carl Kostelezky, Faraz Maneshkarimy, Johanna Mayer-Ismail, Johannes Hilpert, and Uwe Halbig of Paul Hastings LLP act as legal advisor for GENUI GmbH. Fritz Kleweta, Hannes Riedel, Steffen H rner and Hannes Riedel of Herbert Smith Freehills LLP acted as legal advisor for Luxempart (BDL:LXMPR). Sabrina Bremer,Chris Clerihew, Anne Grewlich, Judit Körmöczi of Ashurst has advised Pemberton Asset Management as senior lender and Commerzbank as super senior lender on the financing of Luxempart S.A.?s partnership with VALEARA. Alantra Partners, S.A. (BME:ALNT) act as financial advisor for Luxempart. William Blair act as financial advisor for VALEARA Bottrop GmbH and GENUI GmbH.

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
LUXEMPART	61.50EUR	-2.38%	-0.81%	1.44B
COMMERZBANK AG	30.57EUR	-2.14%	-11.77%	38.52B
ALANTRA PARTNERS, S.A.	8.900EUR	-0.45%	-3.68%	391M

Latest news about Luxempart

02-09	Luxempart S.A. Initiates Succession Process for Managing Director, John Penning	CI
12-19	Luxempart to Become Majority Shareholder in Valeara	MT
12-18	Luxempart agreed to acquire an unknown majority stake in VALEARA Bottrop GmbH from GENUI GmbH and others.	CI
12-04	Luxempart completed the acquisition of The ASSMANN Group from Stephan Assmann.	CI
12/09/25	Luxempart Reports Earnings Results for the Half Year Ended June 30, 2025	CI
12/09/25	Luxempart H1 net asset value at EUR 2.3 billion	RE
28/03/25	Luxempart FY Net Asset Value At EUR 2.31 Bln	RE
27/03/25	Luxempart Proposes Dividend, Payable on 15 May 2025	CI
26/03/25	Luxempart Reports Earnings Results for the Full Year Ended December 31, 2024	CI
02/01/25	TA Associates Management, L.P. completed the acquisition of Nexus AG from Luxempart S.A. and others.	CI
04/11/24	TA Associates Management, L.P. made a tender offer to acquire Nexus AG from Luxempart S.A. and others for ?1.2 billion.	CI
13/09/24	A central bank and it's off again?
11/09/24	Luxempart S.A. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
19/06/24	Medios AG announced that it has received funding from Luxempart S.A.	CI
19/06/24	Luxempart S.A. acquired a 14.9% stake in Medios AG from Manfred Schneider.	CI

Chart Luxempart

Duration

Period

LXMPR: Dynamic Chart

Company Profile

Luxempart SA is a Luxembourg-based investment company which invests in listed and private equity, as well as in private equity funds. The Company is active in Luxembourg, Belgium, France, Italy and Germany, where it manages a portfolio of listed and unlisted companies. Through Luxempart Capital Partners and Indufin Capital Partners (ICP), Luxempart also runs private equity activities. ICP is a joint-venture with the Belgian family holding Eik NV. The Company holds stakes in a number of private companies, including SES, RTL Group, Atenor, Foyer Finance, Foyer SA, SEO, PNE Wind, Pescanova, Mirato, Indufin Capital Partners - ICP Sicar, IEE, Quip, DS Care, Ekkio Capital, Thrombogenics, IP Sante domicile, Octopede Fonds private equity, among others. It also holds a majority stake in Euphaco (ABC Chemical).

Employees

Sector

Investment Management & Fund Operators

Calendar

03-26 - Earnings release - Annual 2025

More about the company